Bioridis Overview

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $14.7K

  • Investors
  • 6

Bioridis General Information

Description

Developer of assays and reagents intended to make advanced biomedical research tools accessible for studying and diagnosing genetic material. The company offers proprietary nucleic acid analysis technology and custom peptide nucleic acid production for gene silencing, enabling life science researchers and diagnostic operators to conduct precise investigations of RNA (Ribonucleic Acid) function and gene regulation.

Contact Information

Website
www.bioridis.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Via Alfonso Rubbiani, 5
  • 40124 Bologna
  • Italy
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Digital Health, HealthTech, Life Sciences
Corporate Office
  • Via Alfonso Rubbiani, 5
  • 40124 Bologna
  • Italy

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bioridis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Accelerator/Incubator 28-Oct-2022 $14.7K Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Accelerator/Incubator Completed Generating Revenue
3. Grant 29-Feb-2020 Completed Generating Revenue
2. Grant 19-Jul-2019 $56.4K Completed Generating Revenue
1. Grant 26-Oct-2015 $5.63K Completed Generating Revenue
To view Bioridis’s complete valuation and funding history, request access »

Bioridis Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • Pending

  • Expiring in next 12 mo

Bioridis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3833781-A1 Method and kit for detecting and/or quantifying a target nucleotide sequence Active 09-Aug-2018
US-20210301330-A1 Method and kit for detecting and/or quantifying a target nucleotide sequence Inactive 09-Aug-2018
WO-2020031142-A1 Method and kit for detecting and/or quantifying a target nucleotide sequence Inactive 09-Aug-2018
EP-3833781-B1 Method for detecting and/or quantifying a target nucleotide sequence Active 09-Aug-2018 C12Q1/6834

Bioridis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bioridis Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
EIT Health Accelerator/Incubator
Horizon 2020 Government
European Institute of Innovation and Technology Government
StartCup Other
CesenaLab Accelerator/Incubator
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Bioridis FAQs

  • Where is Bioridis headquartered?

    Bioridis is headquartered in Bologna, Italy.

  • What is the size of Bioridis?

    Bioridis has 2 total employees.

  • What industry is Bioridis in?

    Bioridis’s primary industry is Discovery Tools (Healthcare).

  • Is Bioridis a private or public company?

    Bioridis is a Private company.

  • What is Bioridis’s current revenue?

    The current revenue for Bioridis is .

  • How much funding has Bioridis raised over time?

    Bioridis has raised $14.7K.

  • Who are Bioridis’s investors?

    EIT Health, Horizon 2020, European Institute of Innovation and Technology, StartCup, and CesenaLab are 5 of 6 investors who have invested in Bioridis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process